CARMELL CORPORATION - COMMON STOCK

Carmell Announces Closing of Previously Announced PIPE Investment from Existing and New Investors to Support Commercial Build-out

03 Jan 2025 08:00:03 By Nasdaq GlobeNewswire

Carmell Announces Execution of Definitive Agreement to Acquire Elevai Skincare, a leader in Physician Dispensed Exosome Skin and Hair Care Products

02 Jan 2025 08:00:23 By Nasdaq GlobeNewswire

Carmell Announces PIPE Investment From Existing and New Investors To Support Commercial Build-out

24 Dec 2024 08:30:00 By Nasdaq GlobeNewswire

Carmell Corporation Launches Skincare Partnership With Ladies Playbook to Support and Celebrate NFL Sports Community

05 Sep 2024 08:30:00 By Nasdaq GlobeNewswire

Carmell Corporation Appoints New CEO Following Addition to the Russell Microcap Index

29 Jul 2024 08:30:00 By Nasdaq GlobeNewswire

Carmell Announces Successful Closing of $3.0 Million Private Placement

11 Apr 2024 16:30:00 By Nasdaq GlobeNewswire

Carmell Announces $3.0 Million Private Placement

04 Apr 2024 08:30:00 By Nasdaq GlobeNewswire

Carmell Announces Successful Closing of Axolotl Biologix Sale Transaction

27 Mar 2024 09:15:00 By Nasdaq GlobeNewswire

Carmell Sharpens Aesthetics Focus with Execution of Definitive Agreement to Sell Axolotl Biologix Subsidiary

20 Mar 2024 16:39:36 By Nasdaq GlobeNewswire

Carmell to Host Investor Webinar, “Unveiling the Secretome: On the Eve of Product Launch” Featuring Key Opinion Leaders in the Medical Aesthetics Field

18 Mar 2024 15:16:22 By Nasdaq GlobeNewswire

Carmell Announces Product Development Completed for G.L.E.E. Launch in March 2024

26 Feb 2024 08:30:00 By Nasdaq GlobeNewswire

Carmell Corp Announces Addition of Scott Frisch and Gilles Spenlehauer to Board of Directors

16 Nov 2023 08:30:00 By Nasdaq GlobeNewswire

Carmell Corporation Announces Completion of Post-Merger Integration with Axolotl Biologix and New Organizational Structure Aligned with Focus on Aesthetics

05 Sep 2023 18:03:11 By Nasdaq GlobeNewswire